Showing 61 - 80 of 167 results
Nuclear medicine congress
Congress marks watershed moment for nuclear medicine and ANSTO
Using light to understand disease
Flexible, printable X-ray detectors
Low-cost X-ray detectors featuring high sensitivity, durability and physical flexibility are required in fields ranging from medical imaging to defence. In this study, a new material for X-ray detection was coupled with inkjet printing to produce a series of prototype X-ray detectors.
Microfluidics: the next wave of disruptive technology in radiochemistry?
Australian Synchrotron to join consortium mapping the human brain
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
DRAXIMAGE MACROSALB®
Medical Research Future Fund Grant targeting glioma with precision radiotherapy and biochemical dose amplification
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
New partnership and nuclear techniques to aid cancer research
Role at ANSTO
Pioneering Australian partnership of art and science reveals hidden masterpiece
Honours for ANSTO Board Member
Studying stonefish venom may help combat transplant rejection
Micro-Computed Tomography beamline (MCT)
With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.
Remarkable clinical trial results shared internationally
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Role at ANSTO
New anti-cancer drugs put cancers to sleep… permanently
Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.
Symposium on advanced therapy
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
A little bit of the moon just landed at ANSTO
Research on lunar meteorite and moon crater analogues coincides with Science Week.